EMSAM
Pronunciation: se-LE-ji-leen (EM-sam)


What it isTransdermal selegiline, an MAOI; major depressive disorder in adults.
Why this oneAt 6 mg/24 h no tyramine diet is needed, because skin delivery spares gut MAO-A.
What limits itTyramine restriction from the first day of 9 or 12 mg/24 h and for 2 weeks after stepping down. Contraindicated with SSRIs, SNRIs, clomipramine, imipramine, meperidine, tramadol, methadone, dextromethorphan and carbamazepine.
Animated chart of estimated U.S. prescriptions per year, Antidepressants (1957–2026). Selegiline transdermal enters in 2006 (estimated).
Legacy pregnancy categoryC
Defining liabilityOrthostasis, hallucinations, dyskinesia and impulse-control symptoms; abrupt withdrawal can be hazardous.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Major depressive disorder | Adults | 6 mg/24 h once daily | 6 mg/24 h | 12 mg/24 h |
| Major depressive disorder | Elderly (≥65 y) | 6 mg/24 h once daily | 6 mg/24 h | 6 mg/24 h |
Titration Increase in 3 mg/24 h increments at intervals of no less than 2 weeks
Renal No adjustment needed (mild, moderate, or severe); not studied in ESRD/dialysis
Hepatic No adjustment needed (mild or moderate Child-Pugh); not studied in severe
Observe washout intervals when switching to/from contraindicated drugs (≥2 weeks after stopping EMSAM; ~1 week (or 5 weeks for fluoxetine) before starting EMSAM)
Available strengths
Pregnancy Insufficient human data; animal studies show malformations and developmental toxicity — potential fetal harm; weigh MAOI risks
Lactation No human data; breastfeeding not recommended during treatment and for 5 days after final dose
| Strength | #/mo | generic $/unit | brand $/unit | CostPlus | |
|---|---|---|---|---|---|
| 6 mg/24 hr | patch | per unit | — | $75.00/ea | not offered |
| 9 mg/24 hr | patch | per unit | — | $75.18/ea | not offered |
| 12 mg/24 hr | patch | per unit | — | $75.40/ea | not offered |
Other forms: Selegiline (ELDEPRYL)
Provisional washout figures
Elevating mechanismMAO-A inhibitor (dose-dependent)
Evidence confidenceHigh
InterpretationEMSAM label 12.2: "at antidepressant doses, selegiline inhibits both isoenzymes... as selegiline concentration increases, this selectivity is lost with resulting dose-related inhibition of MAO-A." A tyramine-modified diet is not required at 6 mg/24 h but IS required at 9 and 12 mg/24 h. No modified diet does not establish SRI compatibility.
Open Selegiline transdermal in the interactive console ↗

Open Selegiline transdermal in the interactive console ↗